Thrive Capital Management (New York) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carvana
CVNA
|
+$36.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Compass
COMP
|
+$57.3M |
| 2 |
Hims & Hers Health
HIMS
|
+$17.1M |
| 3 |
Blend Labs
BLND
|
+$663K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 73.63% |
| 2 | Technology | 10.39% |
| 3 | Consumer Discretionary | 9.9% |
| 4 | Healthcare | 5.9% |
| 5 | Communication Services | 0.18% |
Similar funds
Thrive Capital Management (New York)'s Q2 2022 Portfolio in Review
As of Q2 2022, Thrive Capital Management (New York) held 11 positions worth $342M, down 54% from $741M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Thrive Capital Management (New York) withdrew a net $38.9M in Q2 2022, closing 3 positions. Its most notable exit was Compass, an estimated $57.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 74% of assets, up from 61% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Thrive Capital Management (New York) added an estimated $36.2M to Carvana.
- Thrive Capital Management (New York) added most to Carvana in Q2 2022, an estimated $36.2M increase.
- Thrive Capital Management (New York) fully exited Compass in Q2 2022, selling an estimated $57.3M.
- Thrive Capital Management (New York)'s ten largest holdings make up 100% of its $342M portfolio in Q2 2022.
- Thrive Capital Management (New York) opened 0 new positions and closed 3 in Q2 2022.
- Thrive Capital Management (New York)'s portfolio value fell 54% quarter-over-quarter to $342M.
Based on Thrive Capital Management (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.